Evidence map›Paper›PMID 41799132›Full record

ArticleACS omega2026

Supramolecular Engineering of Melamine-Barbiturate Assemblies for Polyphenol Encapsulation and Antioxidant Delivery.

Liubov A Bridenko, Ivan V Moskalenko, Ilias Z Nishanbaev, Vasiliy A Krylov, Mikhail V Zhukov, Ekaterina V Skorb

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Liubov A BridenkoInfochemistry Scientific Center ITMO University, Lomonosova str. 9, Saint Petersburg 191002, Russian Federation.
Ivan V MoskalenkoInfochemistry Scientific Center ITMO University, Lomonosova str. 9, Saint Petersburg 191002, Russian Federation.
Ilias Z NishanbaevInfochemistry Scientific Center ITMO University, Lomonosova str. 9, Saint Petersburg 191002, Russian Federation.
Vasiliy A KrylovInfochemistry Scientific Center ITMO University, Lomonosova str. 9, Saint Petersburg 191002, Russian Federation.
Mikhail V ZhukovInfochemistry Scientific Center ITMO University, Lomonosova str. 9, Saint Petersburg 191002, Russian Federation.
Ekaterina V SkorbInfochemistry Scientific Center ITMO University, Lomonosova str. 9, Saint Petersburg 191002, Russian Federation.ORCID https://orcid.org/0000-0003-0888-1693

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Supramolecular assemblies of melamine-barbituric acid (Mel-BA) were engineered for the controlled encapsulation of polyphenols, as exemplified by epicatechin (EC). Quantum chemical (DFT) calculations verified the thermodynamic viability of incorporation, although steric and geometric constraints introduced structural defects. EC displayed a binding affinity for Mel-BA higher than that of gallic acid, facilitated by its additional aromatic rings. Encapsulation modulated particle morphology, yielding spherical Mel-BA-GT particles (∼10 μm) and larger, nonspherical Mel-BA-EC assemblies (∼15 μm). The hybrids demonstrated potent antioxidant activity (∼60% over 5 min) with sustained release profiles at pH 8.0, underscoring their delivery potential. The emergence of RHOD-channel fluorescence in the hybrids indicated lattice defect formation upon polyphenol inclusion. Remarkably, electron paramagnetic resonance revealed that carbon-centered radicals within Mel-BA-GT remained stable, implying spatial segregation between matrix-encapsulated polyphenols and surface-localized radicals. This work advances the design of multifunctional supramolecular platforms for targeted delivery and catalysis.

Identifiers

PMID41799132
PMCPMC12961471

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.